<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>12(1)</volume><submitter>Wang G</submitter><pubmed_abstract>In addition to increasing the expression of programmed death-ligand 1 (PD-L1), tumor cells can also secrete exosomal PD-L1 to suppress T cell activity. Emerging evidence has revealed that exosomal PD-L1 resists immune checkpoint blockade, and may contribute to resistance to therapy. In this scenario, suppressing the secretion of tumor-derived exosomes may aid therapy. Here, we develop an assembly of exosome inhibitor (GW4869) and ferroptosis inducer (Fe&lt;sup>3+&lt;/sup>) via amphiphilic hyaluronic acid. Cooperation between the two active components in the constructed nanounit induces an anti-tumor immunoresponse to B16F10 melanoma cells and stimulates cytotoxic T lymphocytes and immunological memory. The nanounit enhances the response to PD-L1 checkpoint blockade and may represent a therapeuti</pubmed_abstract><journal>Nature communications</journal><pagination>5733</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8484261</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis.</pubmed_title><pmcid>PMC8484261</pmcid><pubmed_authors>Li W</pubmed_authors><pubmed_authors>Sang W</pubmed_authors><pubmed_authors>Yan J</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Zhang Z</pubmed_authors><pubmed_authors>Tian H</pubmed_authors><pubmed_authors>Tian Y</pubmed_authors><pubmed_authors>Xie L</pubmed_authors><pubmed_authors>Wang G</pubmed_authors><pubmed_authors>Li B</pubmed_authors><pubmed_authors>Dai Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis.</name><description>In addition to increasing the expression of programmed death-ligand 1 (PD-L1), tumor cells can also secrete exosomal PD-L1 to suppress T cell activity. Emerging evidence has revealed that exosomal PD-L1 resists immune checkpoint blockade, and may contribute to resistance to therapy. In this scenario, suppressing the secretion of tumor-derived exosomes may aid therapy. Here, we develop an assembly of exosome inhibitor (GW4869) and ferroptosis inducer (Fe&lt;sup>3+&lt;/sup>) via amphiphilic hyaluronic acid. Cooperation between the two active components in the constructed nanounit induces an anti-tumor immunoresponse to B16F10 melanoma cells and stimulates cytotoxic T lymphocytes and immunological memory. The nanounit enhances the response to PD-L1 checkpoint blockade and may represent a therapeuti</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Sep</publication><modification>2025-04-21T17:34:58.053Z</modification><creation>2025-04-21T17:34:58.053Z</creation></dates><accession>S-EPMC8484261</accession><cross_references><pubmed>34593794</pubmed><doi>10.1038/s41467-021-25990-w</doi></cross_references></HashMap>